Conditional deletion of the immunoglobulin kappa light-chain (Igκ) downstream enhancers E3' and Ed in mature mouse B cells silences the Igκ locus, drives partial dedifferentiation with re-expression of the V(D)J recombinase genes RAG-1 and RAG-2, and permits secondary Igλ gene rearrangement, demonstrating that mature peripheral B cells retain the machinery for receptor editing and raising the possibility that peripheral editing serves as a B cell tolerance mechanism (Zhou et al., 2013). The open problem is whether RAG-mediated secondary immunoglobulin gene rearrangement (receptor editing or receptor revision) genuinely operates at measurable frequency in mature follicular and germinal-center B cells of intact animals, whether it contributes to maintaining peripheral B cell tolerance, and how editing cells survive the loss of surface immunoglobulin light chain. The discriminating experiment proposed by the source study, compartment-specific conditional RAG knockout separately in mature peripheral and germinal-center B cells followed by tolerance testing, has not been reported, and all post-2013 evidence of peripheral RAG re-induction comes from engineered or pathological settings.

Background

B lymphocytes recognize antigen through the B cell antigen receptor (BCR), a membrane antibody built from immunoglobulin heavy and light chains. In developing bone-marrow B cells, the genes encoding the variable (antigen-binding) part of each chain are assembled from variable (V), diversity (D), and joining (J) gene segments by V(D)J recombination, a DNA cutting-and-joining reaction catalyzed by the RAG-1/RAG-2 recombinase at recombination signal sequences flanking the gene segments. Developing B cells whose BCR binds the body's own antigens can be rescued from deletion by receptor editing: secondary light-chain rearrangement (first at the Igκ locus, then at the Igλ locus) replaces the self-reactive light chain. Receptor editing is a canonical central tolerance mechanism, studied mainly in immature bone-marrow B cells; the bone-marrow stromal factor interleukin-7 and its receptor support recombinase activity in early B cells.

Mature B cells that leave the bone marrow are thought to diversify their receptors only by somatic hypermutation and class-switch recombination in germinal centers — the structures where antigen-activated B cells proliferate and are selected — rather than by V(D)J recombination. Nevertheless, starting in 1996, RAG-1/RAG-2 expression was repeatedly reported in activated mouse B cells and in germinal-center B cells, and in human tonsil germinal-center B cells, where BCR cross-linking extinguishes recombinase expression. Analysis of human tonsil and rheumatoid synovium B cells suggested heavy-chain V-gene replacement ('receptor revision'), but a rigorous single-cell study of human memory B cells found that revision contributes negligibly (an upper bound near 3%) after the onset of somatic hypermutation. In mice, RAG protein was detected in antigen-activated mature B cells during autoantibody responses, where it diminished the autoreactive response, and activated DNA-repair-deficient splenic B cells were shown to accumulate V(D)J-recombination-associated DNA breaks that form oncogenic translocations — work whose authors explicitly noted that 'the occurrence of V(D)J recombination in peripheral B cells is controversial.' The physiological prevalence of peripheral editing and its contribution to tolerance in intact animals therefore remained unsettled.

Zhou, Xiang, Ding, and Garrard (2013) addressed this genetically. The mouse Igκ locus is controlled by cis-regulatory enhancer elements, including the intronic enhancer MiEκ and two downstream enhancers, E3' (also called 3'Eκ) and Ed, which are essential but redundant for establishing Igκ transcription. Deleting E3' conditionally in mature B cells carrying Ed-null alleles caused rapid Igκ silencing and loss of active histone modifications in nonreplicating chromatin, and the cells partially dedifferentiated — inducing RAG-1 and RAG-2 together with pro-B-cell markers (the surrogate light-chain proteins VpreB and λ5, terminal deoxynucleotidyl transferase, and the interleukin-7 receptor) — and then redifferentiated after rearranging Igλ genes. The resulting B220+Igκ−Igλ− cells (B220, also called CD45R, is a standard B-lineage surface marker; the notation denotes cells lacking surface κ and λ light chains) retained surface μ and δ immunoglobulin heavy chains (of the IgM and IgD isotypes) and BAFF-R (the receptor for the B cell survival factor BAFF), which the authors proposed might mimic BCR signaling and prevent death until a new light chain is made. This established that mature B cells are competent to edit, but in an engineered system; the paper itself states that its result only 'raises the possibility' that peripheral receptor editing eliminates autoreactive B cells as a tolerance mechanism.

Problem Statement

Determine whether RAG-mediated secondary immunoglobulin gene rearrangement — receptor editing (light-chain replacement) or receptor revision (rearrangement after the germinal-center reaction has begun) — physiologically operates in mature peripheral B cells and functions as a peripheral B cell tolerance mechanism. The problem decomposes into three linked sub-goals:

(1) Physiological prevalence: whether mature follicular B cells and germinal-center B cells in non-engineered mice, or in healthy humans, re-express functional RAG-1/RAG-2 and execute productive secondary Igκ-to-Igλ (or heavy-chain) rearrangements; at what frequency; and in which activation states or anatomical sites — as distinct from the engineered competence demonstrated by E3'/Ed enhancer deletion.

(2) Tolerance function: whether abrogating RAG activity specifically in mature peripheral B cells, versus specifically in germinal-center B cells (with bone-marrow development left intact), breaks peripheral B cell tolerance — producing expansion of autoreactive B cells or autoantibodies — thereby assigning the relative contributions of peripheral receptor editing and germinal-center receptor revision to tolerance maintenance. This is the discriminating experiment proposed by the source study and it remains unperformed.

(3) Cellular basis: whether B cells undergoing peripheral editing survive the period without surface immunoglobulin light chain through retained surface μ and δ heavy chains and BAFF-R signaling, as observed in the enhancer-deletion model; and whether RAG re-expression in the light-chain-negative population is uniform or confined to a small subpopulation reaching pro-B-cell levels of RAG (the source's own unresolved question).

The related but mechanistically separable question left by the same study — why loss of the E3' enhancer triggers rapid transcriptional silencing and loss of positive histone marks in nonreplicating chromatin (for example, whether disruption of enhancer-promoter chromatin looping is causal, and which trans-acting factors execute the collapse of the active state) — is noted as an adjacent open thread but is not part of this problem's completion boundary.

References

  1. Zhou X, Xiang Y, Ding X, Garrard WT (2013) Loss of an Igκ Gene Enhancer in Mature B Cells Results in Rapid Gene Silencing and Partial Reversible Dedifferentiation. Molecular and Cellular Biology 33(10):2091-2101. doi:10.1128/MCB.01569-12. https://doi.org/10.1128/MCB.01569-12
  2. Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H (1996) Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 274(5295):2092-2094. doi:10.1126/science.274.5295.2092. https://doi.org/10.1126/science.274.5295.2092
  3. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G (1996) Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274(5295):2094-2097. doi:10.1126/science.274.5295.2094. https://doi.org/10.1126/science.274.5295.2094
  4. Hikida M, Nakayama Y, Yamashita Y, Kumazawa Y, Nishikawa SI, Ohmori H (1998) Expression of recombination activating genes in germinal center B cells: involvement of interleukin 7 (IL-7) and the IL-7 receptor. Journal of Experimental Medicine 188(2):365-372. doi:10.1084/jem.188.2.365. https://doi.org/10.1084/jem.188.2.365
  5. Meffre E, Papavasiliou F, Cohen P, de Bouteiller O, Bell D, Karasuyama H, Schiff C, Banchereau J, Liu YJ, Nussenzweig MC (1998) Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. Journal of Experimental Medicine 188(4):765-772. doi:10.1084/jem.188.4.765. https://doi.org/10.1084/jem.188.4.765
  6. Wilson PC, Wilson K, Liu YJ, Banchereau J, Pascual V, Capra JD (2000) Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. Journal of Experimental Medicine 191(11):1881-1894. doi:10.1084/jem.191.11.1881. https://doi.org/10.1084/jem.191.11.1881
  7. Itoh K, Meffre E, Albesiano E, Farber A, Dines D, Stein P, Asnis SE, Furie RA, Jain RI, Chiorazzi N (2000) Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. Journal of Experimental Medicine 192(8):1151-1164. doi:10.1084/jem.192.8.1151. https://doi.org/10.1084/jem.192.8.1151
  8. Horcher M, Souabni A, Busslinger M (2001) Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14(6):779-790. doi:10.1016/S1074-7613(01)00153-4. https://doi.org/10.1016/S1074-7613(01)00153-4
  9. Goossens T, Bräuninger A, Klein U, Küppers R, Rajewsky K (2001) Receptor revision plays no major role in shaping the receptor repertoire of human memory B cells after the onset of somatic hypermutation. European Journal of Immunology 31(12):3638-3648. doi:10.1002/1521-4141(200112)31:12<3638::AID-IMMU3638>3.0.CO;2-G. https://doi.org/10.1002/1521-4141(200112)31:12%3C3638::AID-IMMU3638%3E3.0.CO;2-G
  10. Rice JS, Newman J, Wang C, Michael DJ, Diamond B (2005) Receptor editing in peripheral B cell tolerance. Proceedings of the National Academy of Sciences USA 102(5):1608-1613. doi:10.1073/pnas.0409217102. https://doi.org/10.1073/pnas.0409217102
  11. Wang YH, Diamond B (2008) B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. Journal of Clinical Investigation 118(8):2896-2907. doi:10.1172/JCI35618. https://doi.org/10.1172/JCI35618
  12. Wang JH, Gostissa M, Yan CT, Goff P, Hickernell T, Hansen E, Difilippantonio S, Wesemann DR, Zarrin AA, Rajewsky K, Nussenzweig A, Alt FW (2009) Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 460(7252):231-236. doi:10.1038/nature08159. https://doi.org/10.1038/nature08159
  13. Jiang T, Raviram R, Snetkova V, Rocha PP, Proudhon C, Badri S, Bonneau R, Skok JA, Kluger Y (2016) Identification of multi-loci hubs from 4C-seq demonstrates the functional importance of simultaneous interactions. Nucleic Acids Research 44(18):8714-8725. doi:10.1093/nar/gkw568. https://doi.org/10.1093/nar/gkw568
  14. Pathak S, Kumar KR, Kanta H, Carr-Johnson F, Han J, Bashmakov A, Faure L, Ding H, Vanarsa K, Khan S, Li QZ, Chapman K, Wakeland EK, Mohan C (2016) Fatty Acid Amide Hydrolase Regulates Peripheral B Cell Receptor Revision, Polyreactivity, and B1 Cells in Lupus. Journal of Immunology 196(4):1507-1516. doi:10.4049/jimmunol.1500291. https://doi.org/10.4049/jimmunol.1500291
  15. Totonchy J, Osborn JM, Chadburn A, Nabiee R, Argueta L, Mikita G, Cesarman E (2018) KSHV induces immunoglobulin rearrangements in mature B lymphocytes. PLoS Pathogens 14(4):e1006967. doi:10.1371/journal.ppat.1006967. https://doi.org/10.1371/journal.ppat.1006967
  16. Collins AM, Watson CT (2018) Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire. Frontiers in Immunology 9:2249. doi:10.3389/fimmu.2018.02249. https://doi.org/10.3389/fimmu.2018.02249
  17. Cashman KS, Jenks SA, Woodruff MC, Tomar D, Tipton CM, Scharer CD, Lee FE, Boss JM, Sanz I (2019) Understanding and measuring human B cell tolerance and its breakdown in autoimmune disease. Immunological Reviews 292(1):76-89. doi:10.1111/imr.12820. https://doi.org/10.1111/imr.12820
  18. Okoreeh MK, Kennedy DE, Emmanuel AO, Veselits M, Moshin A, Ladd RH, Erickson S, McLean KC, Madrigal B, Nemazee D, Maienschein-Cline M, Mandal M, Clark MR (2022) Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editing. Science Immunology 7(74):eabm1664. doi:10.1126/sciimmunol.abm1664. https://doi.org/10.1126/sciimmunol.abm1664
  19. Victora GD, Nussenzweig MC (2022) Germinal Centers. Annual Review of Immunology 40:413-442. doi:10.1146/annurev-immunol-120419-022408. https://doi.org/10.1146/annurev-immunol-120419-022408
  20. Crescioli S, Correa I, Ng J, Willsmore ZN, Laddach R, Chenoweth A, Chauhan J, Di Meo A, Stewart A, Kalliolia E, Alberts E, Adams R, Harris RJ, Mele S, Pellizzari G, Black ABM, Bax HJ, Cheung A, Nakamura M, Hoffmann RM, Terranova-Barberio M, Ali N, Batruch I, Soosaipillai A, Prassas I, Ulndreaj A, Chatanaka MK, Nuamah R, Kannambath S, Dhami P, Geh JLC, MacKenzie Ross AD, Healy C, Grigoriadis A, Kipling D, Karagiannis P, Dunn-Walters DK, Diamandis EP, Tsoka S, Spicer J, Lacy KE, Fraternali F, Karagiannis SN (2023) B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma. Nature Communications 14(1):3378. doi:10.1038/s41467-023-39042-y. https://doi.org/10.1038/s41467-023-39042-y
  21. Lu B, Zhang Y, Wang J, Yang D, Liu M, Ma L, Yi W, Liang Y, Xu Y, Fan H, Liu W, Tang J, Zeng S, Cai L, Zhang L, Nie J, Zhang F, Gu X, Rosa Duque JS, Lu G, Zhang Y (2024) PD1+CD4+ T cells promote receptor editing and suppress autoreactivity of CD19+CD21low B cells within the lower respiratory airways in adenovirus pneumonia. Mucosal Immunology 17(5):1045-1059. doi:10.1016/j.mucimm.2024.07.005. https://doi.org/10.1016/j.mucimm.2024.07.005
  22. Oleinika K, Correia Ferreira A, Mouftakir S, Castrillon C, Madungwe L, Nair U, Batista FD, Carroll MC (2025) Dynamic control of autoreactive B cells from spontaneous germinal centers. Journal of Immunology 214(12):3208-3217. doi:10.1093/jimmun/vkaf223. https://doi.org/10.1093/jimmun/vkaf223
  23. Yang F, Zhang B, Liu Y, Feng Z, Xu Y, Hu Z, Li C, Mo C, He J, Liao S, Hou X (2025) TCR/BCR Secondary Rearrangement in Autoimmune Diseases: Molecular Mechanisms, Pathogenic Roles, and Therapeutic Frontiers. Immunological Investigations 54(8):1364-1385. doi:10.1080/08820139.2025.2556781. https://doi.org/10.1080/08820139.2025.2556781
  24. Li X, Hu H, Zhang Y, Zhu T, Guan Y, Xu K, Lin X, Hebert C, Batra H, Zhou J, Ba Z, Wesemann DR, Ye AY, Alt FW (2026) Linear RAG scanning mediates editing of Igκ variable region repertoires. Nature 653(8115):870-878. doi:10.1038/s41586-026-10362-5. https://doi.org/10.1038/s41586-026-10362-5